210 related articles for article (PubMed ID: 32525566)
1. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
Liu T; Zeng G; Tao H; Shi Y; ; Wang T; Liu T; Guo F; Zhou F; Wang X
Int J Cancer; 2020 Dec; 147(11):3267-3269. PubMed ID: 32525566
[No Abstract] [Full Text] [Related]
2. Serosurvey of SARS-CoV-2 among hospital visitors in China.
Liang W; Lin Y; Bi J; Li J; Liang Y; Wong SS; Zanin M; Yang Z; Li C; Zhong R; Jiang G; Han G; Hu D; He J; Zhong N
Cell Res; 2020 Sep; 30(9):817-818. PubMed ID: 32686766
[No Abstract] [Full Text] [Related]
3. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
[No Abstract] [Full Text] [Related]
4. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
Lin Q; Zhu L; Ni Z; Meng H; You L
J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
[No Abstract] [Full Text] [Related]
5. Detection of serum IgM and IgG for COVID-19 diagnosis.
Zhong L; Chuan J; Gong B; Shuai P; Zhou Y; Zhang Y; Jiang Z; Zhang D; Liu X; Ma S; Huang Y; Lin H; Wang Q; Huang L; Jiang D; Hao F; Tang J; Zheng C; Yu H; Wang Z; Jiang Q; Zeng T; Luo M; Zeng F; Zeng F; Liu J; Tian J; Xu Y; Long T; Xu K; Yang X; Liu Y; Shi Y; Jiang L; Yang Z
Sci China Life Sci; 2020 May; 63(5):777-780. PubMed ID: 32270436
[No Abstract] [Full Text] [Related]
6. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
Roeker LE; Knorr DA; Pessin MS; Ramanathan LV; Thompson MC; Leslie LA; Zelenetz AD; Mato AR
Leukemia; 2020 Nov; 34(11):3047-3049. PubMed ID: 32855439
[No Abstract] [Full Text] [Related]
7. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?
Thevis M; Knoop A; Schaefer MS; Dufaux B; Schrader Y; Thomas A; Geyer H
Drug Test Anal; 2020 Jul; 12(7):994-997. PubMed ID: 32386354
[No Abstract] [Full Text] [Related]
8. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
[TBL] [Abstract][Full Text] [Related]
9. Serum IgA, IgM, and IgG responses in COVID-19.
Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
[No Abstract] [Full Text] [Related]
10. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Rijkers G; Murk JL; Wintermans B; van Looy B; van den Berge M; Veenemans J; Stohr J; Reusken C; van der Pol P; Reimerink J
J Infect Dis; 2020 Sep; 222(8):1265-1269. PubMed ID: 32726417
[TBL] [Abstract][Full Text] [Related]
11. Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2.
Hu X; An T; Situ B; Hu Y; Ou Z; Li Q; He X; Zhang Y; Tian P; Sun D; Rui Y; Wang Q; Ding D; Zheng L
J Clin Lab Anal; 2020 Sep; 34(9):e23411. PubMed ID: 32594577
[TBL] [Abstract][Full Text] [Related]
12. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to SARS-CoV-2 in patients with COVID-19.
Long QX; Liu BZ; Deng HJ; Wu GC; Deng K; Chen YK; Liao P; Qiu JF; Lin Y; Cai XF; Wang DQ; Hu Y; Ren JH; Tang N; Xu YY; Yu LH; Mo Z; Gong F; Zhang XL; Tian WG; Hu L; Zhang XX; Xiang JL; Du HX; Liu HW; Lang CH; Luo XH; Wu SB; Cui XP; Zhou Z; Zhu MM; Wang J; Xue CJ; Li XF; Wang L; Li ZJ; Wang K; Niu CC; Yang QJ; Tang XJ; Zhang Y; Liu XM; Li JJ; Zhang DC; Zhang F; Liu P; Yuan J; Li Q; Hu JL; Chen J; Huang AL
Nat Med; 2020 Jun; 26(6):845-848. PubMed ID: 32350462
[TBL] [Abstract][Full Text] [Related]
15. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
16. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
Kerber AA; Soma DB; Youssef MJ
Int J Dermatol; 2020 Aug; 59(8):1024-1025. PubMed ID: 32496578
[No Abstract] [Full Text] [Related]
17. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2.
Decru B; Van Elslande J; Weemaes M; Houben E; Empsen I; André E; Van Ranst M; Lagrou K; Vermeersch P
Clin Chem Lab Med; 2020 Sep; 58(10):e197-e199. PubMed ID: 32628628
[No Abstract] [Full Text] [Related]
18. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood.
Wang Z; Zheng Z; Hu H; Zhou Q; Liu W; Li X; Liu Z; Wang Y; Ma Y
Lab Chip; 2020 Nov; 20(22):4255-4261. PubMed ID: 33064114
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 antibody performances: we need better criteria.
Galli C; Plebani M
Clin Chem Lab Med; 2020 Sep; 58(12):e303-e305. PubMed ID: 32970607
[No Abstract] [Full Text] [Related]
20. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
